16 November 2015 - Competition among generic drug makers pushes drug prices downward. But such competition is weak for a growing and expensive class of drugs called biologics. A big reason has to do with the science that underlies them.

For more details, go to: http://www.nytimes.com/2015/11/17/upshot/how-to-decrease-prices-for-an-expensive-class-of-drugs.html?_r=0